Gross Margin - CJ Bioscience Inc (KOSDAQ:311690) - Alpha Spread
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 12 000 KRW 1.1% Market Closed
Market Cap: 109.4B KRW
Have any thoughts about
CJ Bioscience Inc?
Write Note

Gross Margin
CJ Bioscience Inc

26.4%
Current
34%
Average
47.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
26.4%
=
Gross Profit
1.3B
/
Revenue
4.9B

Gross Margin Across Competitors

Country KR
Market Cap 109.4B KRW
Gross Margin
26%
Country US
Market Cap 34.8B USD
Gross Margin
73%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 18B AUD
Gross Margin
100%
Country US
Market Cap 7.6B USD
Gross Margin
90%
Country JP
Market Cap 986.6B JPY
Gross Margin
58%
Country US
Market Cap 6.3B USD
Gross Margin
85%
Country SE
Market Cap 51.6B SEK
Gross Margin
47%
Country US
Market Cap 4.6B USD
Gross Margin
67%
Country US
Market Cap 3.6B USD
Gross Margin
19%
Country US
Market Cap 2.4B EUR
Gross Margin
66%

Profitability Report

View the profitability report to see the full profitability analysis for CJ Bioscience Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
26.4%
=
Gross Profit
1.3B
/
Revenue
4.9B
What is the Gross Margin of CJ Bioscience Inc?

Based on CJ Bioscience Inc's most recent financial statements, the company has Gross Margin of 26.4%.